These results highlight that SF3B1 mutation–induced splice variants contribute to cancer progression in a cellular context– and disease-dependent manner, underscoring the need to assess the functional impact of SF3B1 mutations tailored to specific diseases. Here, SF3B1 is linked to cancer.